Rare malignant tumors of the lung
Among the rare malignant tumors of the lung, the vast majority are peripheral tumors, and nearly half of the patients have no clinical symptoms. Among them, lymphoma accounts for 41%, carcinosarcoma accounts for 20%, mucoepidermal carcinoma accounts for 15%, sarcoma accounts for 18%, and the rest are malignant melanoma.
-
Site of disease:
lung -
Infectious :
Not contagious -
Frequent population:
Adults -
Related symptoms:
Night sweats pulmonary consolidation weakened breath sounds fatigue cough -
Concurrent disease:
Related Drugs
Gemcitabine Hydrochloride for Injection
Indication: Suitable for the treatment of intermediate and advanced non-small cell lung cancer.
Manufacturer:
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
Gemcitabine Hydrochloride for Injection
Indication: Suitable for the treatment of intermediate and advanced non-small cell lung cancer.
Manufacturer:
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
Related Ingredients